Alopecia - Pipeline Review, H2 2019

Published by Global Markets Direct on 18th November 2019 | Ref: 1464085 | This Product Is In Stock

$2000 | Single User
$4000 | Site License
$6000 | Enterprise License
$2000 | Single User
$4000 | Site License
$6000 | Enterprise License

Introduction

Alopecia - Pipeline Review, H2 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alopecia - Pipeline Review, H2 2019, provides an overview of the Alopecia (Dermatology) pipeline landscape.

Alopecia is the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, irritants, toxins, burns, injuries, and infections.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alopecia - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Alopecia (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 6, 17, 7, 1, 15 and 11 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 3 molecules, respectively.

Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology).

- The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Alopecia - Overview

Alopecia - Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Alopecia - Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Alopecia - Companies Involved in Therapeutics Development

Aclaris Therapeutics Inc

Allergan Plc

Almirall SA

Berg LLC

BiologicsMD Inc

BirchBioMed Inc

Brickell Biotech Inc

Cassiopea SpA

Concert Pharmaceuticals Inc

Dong-A Socio Holdings Co Ltd

Eli Lilly and Co

Energenesis Biomedical Co Ltd

Follica Inc

Histogen Inc

Japan Tobacco Inc

Jiangsu Hengrui Medicine Co Ltd

JW Pharmaceutical Corp

Kuhnil Pharmaceutical Co Ltd

Lee's Pharmaceutical Holdings Ltd

Nepsone ehf

OliX Pharmaceuticals Inc

Pfizer Inc

Phio Pharmaceuticals Corp

Portola Pharmaceuticals Inc

Quark Pharmaceuticals Inc

Samumed LLC

Suzhou Ribo Life Sciences Co Ltd

Suzhou Zelgen Biopharmaceutical Co Ltd

Taisho Pharmaceutical Holdings Co Ltd

Tigo GmbH

Alopecia - Drug Profiles

(cyclosporine A + minoxidil + RT-175) - Drug Profile

AB-101 - Drug Profile

AB-102 - Drug Profile

AB-103 - Drug Profile

AB-105 - Drug Profile

AD-106 - Drug Profile

AD-208 - Drug Profile

AI-001 - Drug Profile

ATI-1777 - Drug Profile

ATI-501 - Drug Profile

ATI-502 - Drug Profile

baricitinib - Drug Profile

BBI-5000 - Drug Profile

BMD-1141 - Drug Profile

BNZ-1 - Drug Profile

BQ-A - Drug Profile

brepocitinib tosylate - Drug Profile

BRM-421 - Drug Profile

calcitriol - Drug Profile

CB-0311 - Drug Profile

cerdulatinib - Drug Profile

clascoterone - Drug Profile

CTP-543 - Drug Profile

CWL-080061 - Drug Profile

delgocitinib - Drug Profile

Drug for Alopecia Areata - Drug Profile

Drugs to Agonize Aryl Hydrocarbon Receptor for Alopecia, Vitiligo and Pemphigus - Drug Profile

ENERGIF-701 - Drug Profile

finasteride - Drug Profile

finasteride - Drug Profile

FOL-005 - Drug Profile

Gene Therapy to Inhibit SRD5A2 for Androgenic Alopecia - Drug Profile

HC-0100 - Drug Profile

HC-017AA - Drug Profile

HST-001 - Drug Profile

interferon beta-1b - Drug Profile

jaktinib hydrochloride - Drug Profile

KI-1104 - Drug Profile

KI-1105 - Drug Profile

KX-826 - Drug Profile

lithium gluconate - Drug Profile

Max-3 - Drug Profile

minoxidil - Drug Profile

minoxidil - Drug Profile

OLX-104 - Drug Profile

PF-06651600 - Drug Profile

Alopecia - Dormant Projects

Alopecia - Discontinued Products

Alopecia - Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Additional Details

Publisher

Global Markets Direct

Publisher Information

Reference

1464085 | GMDHC11421IDB

Number of Pages

184

Report Format

PDF

Related Reports

Title
Date Published
Price From
Link

Published by Global Data
25-10-2018

$2,500 USD

Published by Global Markets Direct
17-07-2018

$2,000 USD

Published by Global Markets Direct
30-01-2018

$2,000 USD

Published by StratisticsMRC
01-11-2017

$4,150 USD

Published by Global Markets Direct
11-07-2017

$2,000 USD

Published by Global Data
31-03-2017

$2,500 USD

Published by Global Data
31-03-2017

$2,500 USD

Published by Global Markets Direct
28-02-2017

$2,000 USD

Published by Global Markets Direct
30-12-2016

$2,000 USD

This report is published by Global Markets Direct

Global Markets Direct is a global market intelligence services company providing information research and analysis products and services.

Their highly qualified team of Researchers, Analysts and Solution Consultants use proprietary data sources and various tools and techniques to gather, analyse and represent the latest and the most reliable information essential for businesses to sustain a competitive edge.

Download Free Report Summary PDF

Alopecia - Pipeline Review, H2 2019 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.